Vaccine

PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2023 Financial Results

Staff May 4, 2023

FLORHAM PARK, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...

TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases

Staff May 4, 2023

FORT WORTH, Texas, May 04, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company...

Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments

Staff May 4, 2023

Aaron Foster, Ph.D., Appointed to Chief Scientific Officer and Eric Soller, Ph.D., Appointed to Chief Business OfficerSeattle, WA, May 04,...

Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023

Staff May 4, 2023

HOLLISTER, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...

SIGA Declares Special Cash Dividend of $0.45 Per Share

Staff May 4, 2023

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced...

Arbutus Reports First Quarter 2023 Financial Results and Corporate Update

Staff May 4, 2023

Additional AB-729 off-treatment data highlighted in an oral presentation at the Global Hepatitis Summit 2023 Dosed first subject in Phase...

Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital

Staff May 3, 2023

MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...

Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention

Staff May 2, 2023

– New grant from the Bill & Melinda Gates Foundation supports the Phase 1 development of VIR-1388, an investigational HIV...

Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody

Staff May 1, 2023

Providence, RI, May 01, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the...

Ring Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategy

Staff May 1, 2023

McNulty brings deep experience in capital formation and business development to Ring Follows recent appointment of Dr. Christopher Wright as...

Elicio Therapeutics to Present Interim Data from the Ongoing Phase 1 Study of Investigational Therapeutic Cancer Vaccine, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at ASCO

Staff May 1, 2023

BOSTON, May 01, 2023 (GLOBE NEWSWIRE) -- Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for...

ODAIA Raises $25 Million in Series B Funding to Advance Its AI-Driven Commercial Insights Software for Pharma

Staff May 1, 2023

With funding, ODAIA to fuel expansion and support the rapid growth of its AI-powered solutions that help pharma companies put...

IN8bio Appoints Jeremy Graff, Ph.D., to Board of Directors

Staff May 1, 2023

Dr. Jeremy Graff spent 17 years at Eli Lilly and Company, where he built and led the translational oncology group,...

Pathways to Cures are in Sight as MS Canada Hosts Annual Day on the Hill with Carnation Pinning

Staff May 1, 2023

OTTAWA, May 01, 2023 (GLOBE NEWSWIRE) -- Dozens of representatives of MS Canada are fanning across Ottawa May 1st – May...

Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO®

Staff May 1, 2023

Media Release Investigator-initiated study jointly funded with Merck KGaA, Darmstadt, Germany, will evaluate dual immuno-oncology (IO) combination of eftilagimod alpha...

TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Staff May 1, 2023

First quarter 2023 BRIUMVI net sales of $7.8 million Over 400 BRIUMVI prescriptions in the first partial quarter from 165+...

TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program

Staff May 1, 2023

FORT WORTH, Texas, May 01, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company...

Capricor Announces Peer-Reviewed Publication Demonstrating the Therapeutic Potential of Exosome-Based Multivalent Vaccine Developed from its StealthX™ Platform

Staff April 27, 2023

-Capricor’s StealthX™ Exosome Platform Designed to Support the Advancement of Next Generation Vaccines and Therapeutics-SAN DIEGO, Calif., April 27, 2023 (GLOBE...

Press Release: Sanofi completes acquisition of Provention Bio, Inc.

Staff April 27, 2023

Sanofi completes acquisition of Provention Bio, Inc. Paris, April 27 2023. Sanofi announced today the completion of its acquisition of...

MI4, Montreal’s powerhouse of infectious disease research, celebrates five years of innovation and philanthropy

Staff April 27, 2023

Vincent Chiara, real estate entrepreneur and founder and President of Groupe Mach donates $1.4 million to the MUCH Foundation for...

Vaccine

PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2023 Financial Results

TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases

Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments

Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023

SIGA Declares Special Cash Dividend of $0.45 Per Share

Arbutus Reports First Quarter 2023 Financial Results and Corporate Update

Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital

Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention

Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody

Ring Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategy

Elicio Therapeutics to Present Interim Data from the Ongoing Phase 1 Study of Investigational Therapeutic Cancer Vaccine, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at ASCO

ODAIA Raises $25 Million in Series B Funding to Advance Its AI-Driven Commercial Insights Software for Pharma

IN8bio Appoints Jeremy Graff, Ph.D., to Board of Directors

Pathways to Cures are in Sight as MS Canada Hosts Annual Day on the Hill with Carnation Pinning

Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO®

TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program

Capricor Announces Peer-Reviewed Publication Demonstrating the Therapeutic Potential of Exosome-Based Multivalent Vaccine Developed from its StealthX™ Platform

Press Release: Sanofi completes acquisition of Provention Bio, Inc.

MI4, Montreal’s powerhouse of infectious disease research, celebrates five years of innovation and philanthropy

The WISH Clinic Partnering With Clara Care to Bring Specialized Wound Care Directly to Patients in the Convenience of Their Homes

Chinese Team Secures “Best Showpiece Award” at the 52nd UIBC International Competition for Young Bakers with Angel Yeast’s Support

Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance

EY Announces Alfonso Montiel of SilverStone Health as an Entrepreneur Of The Year® 2024 Southwest Award Finalist

You may have missed